statistiche per SALVETTI, CHIARA

Distribuzione geografica

Continente	#
NA - Nord America	572
EU - Europa	432
AS - Asia	218
AF - Africa	7
Continente sconosciuto - Info sul continente non disponibili	1
SA - Sud America	1
Totale	1231

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	567
CN - Cina	178
IT - Italia	135
AT - Austria	57
DK - Danimarca	50
UA - Ucraina	44
SE - Svezia	42
DE - Germania	32
FR - Francia	28
BY - Bielorussia	13
VN - Vietnam	13
CH - Svizzera	9
IN - India	6
KR - Corea	6
SN - Senegal	6
GB - Regno Unito	5
HK - Hong Kong	5
CA - Canada	4
ES - Italia	4
TH - Thailandia	4
PL - Polonia	3
RU - Federazione Russa	3
FI - Finlandia	2
NL - Olanda	2
RO - Romania	2
UZ - Uzbekistan	2
AR - Argentina	1
EG - Egitto	1
EU - Europa	1
GR - Grecia	1
IL - Israele	1
JP - Giappone	1
MX - Messico	1
PH - Filippine	1
TR - Turchia	1
Totale	1231

Salva come PNG Salva come JPEG

Città	#
Beijing	110
Ann Arbor	89
Vienna	57
Dearborn	51
Torino	47
Fairfield	39
Wilmington	39
Jacksonville	32
Houston	30
Woodbridge	27
Fremont	22
San Mateo	18
Seattle	18
Ashburn	17
Cambridge	15
Hangzhou	13
Dong Ket	12
Redwood City	10
Linden	9
Guangzhou	8
Hefei	8
Oerlikon	8
Chengdu	7
Codogno	6
Falls Church	6
Seoul	6
Wayne	6
Casorzo	5
Central District	5
Guiyang	5
Villeurbanne	5
Canelli	4
Duncan	4
Piemonte	4
Rome	4
San Diego	4
San Jose	4
Balingen	3
Changsha	3
Erlangen	3
Leawood	3
Milan	3
Mortara	3
Nanjing	3
Varese	3
Wuhan	3
Bologna	2
Kunming	2
Masnou	2
Napoli	2
Norwalk	2
Pisa	2
Shanghai	2
Shenyang	2
Toronto	2
Trecate	2
Warsaw	2
Wenzhou	2
Bad Endorf	1
Campogalliano	1
Chaoyang	1
Chongqing	1
Collegeville	1
Feltre	1
Fort Collins	1
Harbin	1
Hebei	1
Hirrlingen	1
Hyderabad	1
Izmir	1
Jinan	1
Lake Orion	1
Legnano	1
Mont-saint-aignan	1
Nanchang	1
New York	1
Newtown	1
Ottawa	1
Paris	1
Polska	1
Redmond	1
Riverton	1
Silver Spring	1
Tampa	1
Venezia	1
Viareggio	1
Voorburg	1
Zhengzhou	1
Totale	835

Salva come PNG Salva come JPEG

Nome	#
REGULATION OF HIF-1 alpha IN TP53 DISRUPTED CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND ITS POTENTIAL ROLE AS A THERAPEUTIC TARGET	243
Magic pills: new oral drugs to treat chronic lymphocytic leukemia	92
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia	77
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells, Also Overcoming Intrinsic and Stromal Cells-Mediated Fludarabine Resistance	73
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems	68
Regulation of HIF-1α in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role as a Therapeutic Target	61
Idelalisib nei pazienti con leucemia linfatica cronica e linfoma follicolare: esperienza monocentrica real life	52
Autoimmune complications in chronic lymphocytic leukemia in the era of targeted drugs	49
SELINEXOR (KPT-330) IN COMBINATION WITH CHEMOTHERAPY OR IDELALISIB ELICITS A SYNERGISTIC CYTOTOXIC EFFECT IN PRIMARY CLL CELLS, ALSO OVERCOMING INTRINSIC AND STROMAL CELLS-MEDIATED FLUDARABINE RESISTANCE	47
TARGETING THE CXCR4 DOWNSTREAM SIGNALLING PATHWAYS TO REVERSE MICROENVIRONMENT PROTECTION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS	46
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs	46
TARGETING HIF-1A AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER LEUKEMIA-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA	39
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection	38
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia	35
Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs	35
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target	33
TARGETING HIF-1 AND ITS REGULATORY PATHWAYS AS A STRATEGY TO HAMPER TUMOR-MICROENVIRONMENT INTERACTIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA	32
Ibrutinib Treatment Mitigates Phenotypic Alterations of Non-Neoplastic Immune Cell Compartments in Chronic Lymphocytic Leukemia	31
Modulation of Phenotypic and Functional Features of Immune Cells in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib	27
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells	26
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells	26
Sequential Development of Three Mature Lymphoid Neoplasms in a Single Patient: Clonal Relationship and Molecular Insights	24
Regulation of HIF-1α in TP53 disrupted chronic lymphocytic leukemia cells and its potential role as a therapeutic target	23
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll	21
Selinexor in Combination with Chemotherapy or Idelalisib Elicits a Synergistic Cytotoxic Effect in Primary CLL Cells	17
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantation	15
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia	13
HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia	7
Totale	1296

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	1296
article - articoli	0
book - libri	0
conference - conferenze	856
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	2152

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2016/2017	12	0	0	0	0	0	0	0	0	0	0	5	7
2017/2018	41	2	3	2	0	0	3	4	8	17	2	0	0
2018/2019	132	2	0	0	1	3	0	2	33	13	26	20	32
2019/2020	352	12	5	27	37	22	45	36	22	32	41	32	41
2020/2021	436	29	37	15	40	71	33	29	40	32	20	55	35
2021/2022	323	23	8	19	24	30	8	31	19	14	30	117	0
Totale													1296

CINECA IRIS Institutional Research Information System

statistiche per SALVETTI, CHIARA